01-05-2016, 03:21 PM
|
|
Tripletail
|
|
Join Date: Jul 2009
Location: Lafayette
Posts: 850
Cash: 792
|
|
Quote:
Originally Posted by Baychamp1
I like PFE, the Allergan merger lowers their tax rate by 8% due to the inversion, also with AGN projected FY 2018 earnings @ 21.00 share that's a forward PE of 17 based on the 363.63 takeover price, and the 3.5% div yield ain't bad either. Also Bought OPK, based on recent takeover of Bio Reference Labs and the CEO has been buying like crazy.
|
|